JO1719B1 - Pharmacist - Google Patents
PharmacistInfo
- Publication number
- JO1719B1 JO1719B1 JO19921719A JOP19921719A JO1719B1 JO 1719 B1 JO1719 B1 JO 1719B1 JO 19921719 A JO19921719 A JO 19921719A JO P19921719 A JOP19921719 A JO P19921719A JO 1719 B1 JO1719 B1 JO 1719B1
- Authority
- JO
- Jordan
- Prior art keywords
- hydrogen
- formula
- quinone
- composition
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229910006127 SO3X Inorganic materials 0.000 abstract 1
- 229930182482 anthraquinone glycoside Natural products 0.000 abstract 1
- 229940098421 anthraquinone glycoside Drugs 0.000 abstract 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 abstract 1
- 229940114118 carminic acid Drugs 0.000 abstract 1
- 235000012730 carminic acid Nutrition 0.000 abstract 1
- 239000004106 carminic acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- BDJXVNRFAQSMAA-UHFFFAOYSA-N quinhydrone Chemical compound OC1=CC=C(O)C=C1.O=C1C=CC(=O)C=C1 BDJXVNRFAQSMAA-UHFFFAOYSA-N 0.000 abstract 1
- 229940052881 quinhydrone Drugs 0.000 abstract 1
- DGQOCLATAPFASR-UHFFFAOYSA-N tetrahydroxy-1,4-benzoquinone Chemical compound OC1=C(O)C(=O)C(O)=C(O)C1=O DGQOCLATAPFASR-UHFFFAOYSA-N 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
- C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
- C09B67/0034—Mixtures of two or more pigments or dyes of the same type
- C09B67/0038—Mixtures of anthraquinones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919103075A GB9103075D0 (en) | 1991-02-13 | 1991-02-13 | Trinitrobenzene derivatives and their therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO1719B1 true JO1719B1 (en) | 1992-12-15 |
Family
ID=10689992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO19921719A JO1719B1 (en) | 1991-02-13 | 1992-02-13 | Pharmacist |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0499467A3 (enExample) |
| JP (1) | JPH06505231A (enExample) |
| CN (1) | CN1064407A (enExample) |
| AP (1) | AP549A (enExample) |
| AU (2) | AU1233992A (enExample) |
| BG (1) | BG61025B1 (enExample) |
| BR (1) | BR9205642A (enExample) |
| CA (1) | CA2104009A1 (enExample) |
| CZ (1) | CZ166893A3 (enExample) |
| DZ (1) | DZ1559A1 (enExample) |
| FI (1) | FI933595A7 (enExample) |
| GB (2) | GB9103075D0 (enExample) |
| GT (1) | GT199200009A (enExample) |
| HU (1) | HUT65634A (enExample) |
| IE (1) | IE920464A1 (enExample) |
| IL (1) | IL100906A (enExample) |
| IN (1) | IN178929B (enExample) |
| IS (1) | IS3814A (enExample) |
| JO (1) | JO1719B1 (enExample) |
| LT (1) | LT3197B (enExample) |
| MA (1) | MA22443A1 (enExample) |
| MX (1) | MX9200622A (enExample) |
| MY (1) | MY131098A (enExample) |
| NO (1) | NO932681L (enExample) |
| NZ (2) | NZ240487A (enExample) |
| OA (2) | OA09535A (enExample) |
| SK (1) | SK87993A3 (enExample) |
| TN (1) | TNSN92015A1 (enExample) |
| WO (1) | WO1992014454A1 (enExample) |
| ZA (1) | ZA921037B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9103075D0 (en) | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
| DZ1781A1 (fr) * | 1993-05-21 | 2002-02-17 | Radopah Ltd | Agents d'arylation. |
| IL113025A0 (en) * | 1994-03-17 | 1995-06-29 | Radopath Ltd | Anti-viral and anti-cancer agents |
| EP0705601B1 (de) * | 1994-10-04 | 2000-01-19 | LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik | Lösungen von Anthrachinonen zur parenteralen Applikation |
| US7482029B2 (en) | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
| US7537774B2 (en) * | 2005-12-23 | 2009-05-26 | Orion Therapeautics, Llc | Therapeutic formulation |
| EP2182965A4 (en) | 2007-08-08 | 2010-09-29 | Bionovo Inc | LIGUSTRUM LUCIDUM EXTRACTS AND USES THEREOF |
| WO2009033025A1 (en) | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof |
| EP2190292A4 (en) | 2007-09-07 | 2012-12-26 | Bionovo Inc | ESTROGENWIRKSAME EXTRACTS OF SCUTTELARIA BARBATA D. DON OF THE FAMILY LABIATAE AND ITS USES |
| US20090068298A1 (en) | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF |
| EP2060562A1 (en) * | 2007-11-16 | 2009-05-20 | Laboratoire Medidom S.A. | Dioxoanthracene sulphonate derivatives |
| US8512961B2 (en) | 2007-11-19 | 2013-08-20 | Bionovo, Inc. | Methods of detecting and treatment of cancers using Scutellaria barbata extract |
| JP2011503237A (ja) | 2007-11-19 | 2011-01-27 | バイオノボ・インコーポレーテッド | Ｓｃｕｔｅｌｌａｒｉａｂａｒｂａｔａｄ．ｄｏｎの精製抽出物を作製するためのプロセス |
| WO2009148620A2 (en) * | 2008-06-06 | 2009-12-10 | Bionovo, Inc. | Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions |
| WO2013055913A2 (en) | 2011-10-14 | 2013-04-18 | Emory University | Pgam1 inhibitors and methods related thereto |
| CZ304335B6 (cs) * | 2012-02-22 | 2014-03-12 | Mikrobiologický ústav AV ČR, v. v. i. | Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití |
| KR20210032405A (ko) * | 2018-07-17 | 2021-03-24 | 삘리 | 안트라퀴논 유도체 및 착색제로서의 그의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7708452L (sv) * | 1977-07-22 | 1979-01-23 | Allied Chem | Komposition innehallande en antrakinonforening |
| JPS6054286B2 (ja) * | 1979-09-18 | 1985-11-29 | 江澤 林 | 免疫増強剤 |
| JPS6043210A (ja) * | 1983-08-18 | 1985-03-07 | Tdk Corp | 磁気ヘツド及びその製造方法 |
| DE3431236A1 (de) * | 1984-08-24 | 1986-02-27 | Carnivora-Deutschland GmbH, 7109 Jagsthausen | Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation |
| DE3601065A1 (de) * | 1986-01-16 | 1987-07-23 | Behringwerke Ag | Chinon-derivate als antitumormittel |
| KR920003577B1 (ko) * | 1987-12-10 | 1992-05-04 | 주식회사 쓰무라 | 항 레트로바이러스제 |
| AU633836B2 (en) * | 1988-08-16 | 1993-02-11 | Wellcome Foundation Limited, The | Medicaments |
| GB9103075D0 (en) | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
| FI924475A0 (fi) * | 1990-04-03 | 1992-10-05 | Radopath Ltd | Anvaendning av trinitrobensener och karminsyra vid behandling av canceroch virusbetingade sjukdomar |
| DE4013023A1 (de) * | 1990-04-24 | 1991-11-07 | Lohmann Rudolf Lomapharm | Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen |
-
1991
- 1991-02-13 GB GB919103075A patent/GB9103075D0/en active Pending
- 1991-11-05 NZ NZ240487A patent/NZ240487A/en unknown
-
1992
- 1992-02-10 IN IN97DE1992 patent/IN178929B/en unknown
- 1992-02-10 IL IL10090692A patent/IL100906A/en not_active IP Right Cessation
- 1992-02-11 NZ NZ241593A patent/NZ241593A/en unknown
- 1992-02-12 DZ DZ920016A patent/DZ1559A1/fr active
- 1992-02-12 IS IS3814A patent/IS3814A/is unknown
- 1992-02-12 MA MA22730A patent/MA22443A1/fr unknown
- 1992-02-12 AP APAP/P/1992/000356A patent/AP549A/en active
- 1992-02-13 BR BR9205642A patent/BR9205642A/pt not_active Application Discontinuation
- 1992-02-13 JO JO19921719A patent/JO1719B1/en active
- 1992-02-13 JP JP4504180A patent/JPH06505231A/ja active Pending
- 1992-02-13 SK SK879-93A patent/SK87993A3/sk unknown
- 1992-02-13 CZ CS931668A patent/CZ166893A3/cs unknown
- 1992-02-13 GT GT199200009A patent/GT199200009A/es unknown
- 1992-02-13 CN CN92100817A patent/CN1064407A/zh active Pending
- 1992-02-13 TN TNTNSN92015A patent/TNSN92015A1/fr unknown
- 1992-02-13 MY MYPI92000228A patent/MY131098A/en unknown
- 1992-02-13 EP EP19920301185 patent/EP0499467A3/en not_active Withdrawn
- 1992-02-13 WO PCT/GB1992/000262 patent/WO1992014454A1/en not_active Ceased
- 1992-02-13 MX MX9200622A patent/MX9200622A/es not_active Application Discontinuation
- 1992-02-13 ZA ZA921037A patent/ZA921037B/xx unknown
- 1992-02-13 IE IE046492A patent/IE920464A1/en unknown
- 1992-02-13 GB GB9203084A patent/GB2254554B/en not_active Expired - Fee Related
- 1992-02-13 AU AU12339/92A patent/AU1233992A/en not_active Abandoned
- 1992-02-13 OA OA60150A patent/OA09535A/en unknown
- 1992-02-13 HU HU9302347A patent/HUT65634A/hu unknown
- 1992-02-13 CA CA002104009A patent/CA2104009A1/en not_active Abandoned
-
1993
- 1993-02-05 LT LTIP329A patent/LT3197B/lt not_active IP Right Cessation
- 1993-07-26 NO NO93932681A patent/NO932681L/no unknown
- 1993-08-13 BG BG98041A patent/BG61025B1/bg unknown
- 1993-08-13 OA OA60399A patent/OA09810A/en unknown
- 1993-08-13 FI FI933595A patent/FI933595A7/fi not_active Application Discontinuation
-
1996
- 1996-06-11 AU AU55906/96A patent/AU5590696A/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO1719B1 (en) | Pharmacist | |
| ZA928170B (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid | |
| MY103388A (en) | Azithromycin and derivatives as antiprotozoal agents | |
| GR3027634T3 (en) | Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them. | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| IL75337A0 (en) | Quinone derivative,process for the preparation thereof and pharmaceutical compositions containing the same | |
| AU4192289A (en) | Novel cc-1065 analogs having two cpi subunits | |
| IL89199A0 (en) | 3'-deamino-4'-deoxy-4'-amino anthracyclines,their preparation and pharmaceutical compositions containing them | |
| TNSN01046A1 (fr) | Ethers de diphenyle utiles en therapeutique | |
| ES2100335T3 (es) | Derivados de benzopirano y fenol para empleo como agentes inmunoestimulantes. | |
| NZ505821A (en) | Pharmaceutical compositions of uridine triphosphate | |
| ZA865192B (en) | New carboxylic acid derivatives,processes for the preparation thereof,the use thereof and pharmaceutical compositions containing them | |
| TW248559B (enExample) | ||
| CA2292226A1 (en) | Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use | |
| ZA948078B (en) | Inclusion complex. | |
| AR003133A1 (es) | Concentrado de complejo de yodo; composicion antimicrobiana acuosa que lo contiene y proceso de limpieza, desinfeccion y esterilizacion de una superficiedeterminada que emplea a esta ultima | |
| CA2107485A1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| KR880008801A (ko) | 비경구 투여용 용액제 | |
| IT1261480B (it) | Composti disazoici basici contenenti gruppi solfo, loro preparazione e loro impiego come coloranti. | |
| EP0134179A3 (en) | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them | |
| IE811443L (en) | Aqueous aldonate compositions | |
| NZ234451A (en) | Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions | |
| AU6520196A (en) | Aqueous compositions containing ciprofloxacine, and related use and process | |
| IL107520A0 (en) | Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them | |
| RU93053490A (ru) | Фармацевтическая композиция |